BIHIMA Reports Q1 2025 Growth in Hearing Instrument Sales
BIHIMA’s Q1 2025 report shows strong growth in hearing instrument sales across the UK and Ireland, with particularly notable increases in NHS and rechargeable device uptake.
BIHIMA’s Q1 2025 report shows strong growth in hearing instrument sales across the UK and Ireland, with particularly notable increases in NHS and rechargeable device uptake.
The new report offers clinical guidance on several topics, including assessment and referral, removing earwax, treating idiopathic sudden sensorineural hearing loss, assessment and management in audiology services, and follow-up audiology services.
Results from a hearing loss survey undertaken in the United Kingdom between October and December 2014 reveal that 46% of British people diagnosed with hearing loss don’t receive any treatment for it.